Handelsavisen
prelaunch
SL
SLSN.O NASDAQ Personal Products

Solesence Inc

$1,02
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
72,0M USD
P/E
EV / Rev
Div yield
Op margin
2,5 %
ROE
10,2 %
Net margin
2,9 %
Debt / equity
0,87
Beta
52w range
Volume
Day range
Prev close
$1,32
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

Solesence Inc designs, develops, and sells innovative footwear solutions, primarily targeting the personal products market.

Business. Solesence Inc (SLSN.O) is a personal products company operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of personal care items, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in the United States, the company is primarily listed on the NASDAQ stock exchange.

Classification99 %
SectorConsumer Staples
Industry groupPersonal Products
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
Geode Capital Management, L.L.C.
largest disclosed fund holder
Profitability
10,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning SLSN.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to SLSN.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Solesence Inc (SLSN.O) is a personal products company operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of personal care items, though specific operating segments and geographic breakdowns are not disclosed. Headquartered in the United States, the company is primarily listed on the NASDAQ stock exchange.

    Classification99 %
    SectorConsumer Staples
    Industry groupPersonal Products
    AI synthesis
    GENERATED

    Solesence Inc has a market capitalization of $92.53 million and a price-to-earnings ratio of 51.69, indicating a high valuation relative to its earnings. The company's price-to-book ratio is 5.25, suggesting that the market values the company significantly above its book value. The enterprise value to EBITDA ratio is 67.75, which is notably high and may reflect investor expectations of future earnings growth or market sentiment. The company's liquidity position is characterized by a current ratio of 2.07, indicating it has sufficient current assets to cover its current liabilities. However, the operating cash flow is negative at -$8.57 million, which could signal short-term liquidity challenges.

    In terms of profitability, Solesence Inc has a return on equity of 10.15% and a return on assets of 3.58%, which are both below the industry median for the Personal Products sector. The company's gross profit margin is 25.88%, and its operating margin is 2.53%, both of which are lower than the industry median. These figures suggest that the company is not as efficient in converting revenue into profit as its peers. The net income margin is 0.29%, which is also below the industry median, indicating that the company is struggling to maintain profitability relative to its revenue.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification could expose the company to higher risk if demand in its primary market declines. The absence of segment or geographic breakdowns in the financial data limits the ability to assess the company's exposure to different markets or product lines.

    Solesence Inc's growth trajectory is uncertain, as the available data does not provide specific revenue growth rates or future projections. The company's capital expenditure of -$2.14 million indicates a reduction in investment in long-term assets, which could signal a strategic shift or financial constraints. The free cash flow of $544,000 is positive but relatively small, which may limit the company's ability to reinvest in growth opportunities or pay dividends.

    The company faces several risk factors, including a medium liquidity risk due to its negative operating cash flow and a debt-to-equity ratio of 0.87. The risk assessment also notes that net cash is negative after subtracting total debt, which could lead to financial distress if not managed properly. The dilution risk is assessed as low, but the company's capital structure and potential for future dilution should be monitored closely.

    Recent events and disclosures do not provide specific details on recent filings or transcripts, but the company's ESG scores indicate moderate social and governance performance. The ESG controversies score of 100.00 suggests that the company has not been involved in any significant controversies, which is a positive sign for its governance and social responsibility practices.

    Key takeaways
    • Solesence Inc is significantly overvalued based on its price-to-earnings and enterprise value to EBITDA ratios.
    • The company's profitability metrics, including return on equity and operating margin, are below industry medians.
    • The company's revenue is not diversified across segments or geographies, increasing its exposure to market-specific risks.
    • The company's liquidity position is weak, with a negative operating cash flow and a debt-to-equity ratio of 0.87.
    • The company's ESG scores suggest moderate social and governance performance with no significant controversies.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $1,02
    Market cap
    $92.5M
    Enterprise value
    $106.5M
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    5.2x
    P / Tangible book
    5.2x
    Tangible book
    $17.6M
    Net cash
    -$14.0M
    Current ratio
    2.1
    Debt / equity
    0.9
    ROA
    3.6%
    ROE
    10.2%
    Cash conversion
    -479.0%
    CapEx / revenue
    -3.5%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    INDUSTRYSEGMENTCOMPANYConsumer Non-CyclicalsIndustryPersonal Products215,0B node revenuePG 39,2%UL 26,8%CL 9,5%KMB 7,7%KVUE 7,0%EL 6,7%ELF 0,8%MATW 0,7%Other 1,7%
    Source: company disclosures · own-taxonomy revenue-covered setSLSN 0,0% · rank #14 of 19

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    Peer comparison8 peers · vs SLSN · multiples and returns
    PG
    PG
    THE PROCTER & GAMBLE COMPANY
    $144,97
    351,7B USD
    P/E
    22,1x
    -29,5 vs self
    Div yield
    2,8 %
    vs self
    ROE
    29,2 %
    +19,0 vs self
    UL
    UL
    UNILEVER PLC
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    CL
    CL
    Colgate-palmolive Co
    $89,71
    72,1B USD
    P/E
    34,4x
    -17,3 vs self
    Div yield
    2,3 %
    vs self
    ROE
    903,4 %
    +893,2 vs self
    KM
    KMB
    KIMBERLY-CLARK INC.
    $108,01
    35,9B USD
    P/E
    60,0x
    +8,3 vs self
    Div yield
    5,2 %
    vs self
    ROE
    47,9 %
    +37,7 vs self
    KV
    KVUE
    KENVUE INC.
    $18,04
    34,6B USD
    P/E
    22,7x
    -29,0 vs self
    Div yield
    4,3 %
    vs self
    ROE
    15,1 %
    +4,9 vs self
    EL
    EL
    Estee Lauder Companies
    $84,68
    30,9B USD
    P/E
    101,7x
    +50,0 vs self
    Div yield
    2,1 %
    vs self
    ROE
    7,5 %
    -2,7 vs self
    EL
    ELF
    Elf Beauty Inc
    $83,56
    5,0B USD
    P/E
    174,5x
    +122,8 vs self
    Div yield
    vs self
    ROE
    2,3 %
    -7,8 vs self
    MA
    MATW
    Matthews Intl Corp
    $28,07
    873,7M USD
    P/E
    vs self
    Div yield
    3,6 %
    vs self
    ROE
    -5,1 %
    -15,2 vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin2,5 %Below median
    Net Margin2,9 %Below median
    ROE10,2 %Above P75
    Capex / Rev-3,5 %Below median
    D/E0,87Bottom quartile
    Cash Conv-4,79Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • Solesence Inc Market data — financials · 2026-05-29
    • Solesence Inc Market data — ESG · 2026-05-29

    Ownership & reference

    Top holders

    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$0M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$2M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$0M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$0M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Leadership

    • Kevin CuretonPresident, Chief Executive Officer, Director

    Insider activity

    Net buying7 buys · 0 sellsnet $68K1 insiders · last 365d
    • WHITMORE R JANETDirector · Common StockBought 1 500 @ $1,91$3K · 2025-12-24
    • WHITMORE R JANETDirector · Common StockBought 1 000 @ $1,92$2K · 2025-12-24
    • WHITMORE R JANETDirector · Common StockBought 5 000 @ $1,95$10K · 2025-11-19
    • WHITMORE R JANETDirector · Common StockBought 5 000 @ $1,89$9K · 2025-11-19
    • WHITMORE R JANETDirector · Common StockBought 267 @ $1,83$489 · 2025-11-18
    • WHITMORE R JANETDirector · Common StockBought 5 000 @ $1,87$9K · 2025-11-17
    • WHITMORE R JANETDirector · Common StockBought 19 789 @ $1,73$34K · 2025-11-14

    Short positioning

    427.6Kshares short+9.8% vs prior
    2.09days to cover
    14.4%short of daily vol
    4fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    SLSN.OCanonical
    NASDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -8.6%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -534.7%Derived (calculated)
    • R&D expense (YoY) (2025-12-31 vs 2024-12-31): 6.6%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -57.1%Derived (calculated)
    • Net margin (FY 2025-12-31): 2.9%Derived (calculated)
    • Gross margin (FY 2025-12-31): 25.9%Derived (calculated)
    • Return on equity (FY 2025-12-31): 10.2%Derived (calculated)
    • Return on assets (FY 2025-12-31): 3.6%Derived (calculated)
    • Current ratio (FY 2025-12-31): 2.07xDerived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): 18.6%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): -57.7%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -71.4%Derived (calculated)
    • Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 27.2%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): -69.4%Derived (calculated)
    • Gross profit (YoY) (2025-12-31 vs 2024-12-31): -0.8%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 18.0%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 0.1%Derived (calculated)
    • Current assets (annual): USD 28.78MSEC XBRL filing
    • Current liabilities (annual): USD 13.93MSEC XBRL filing
    • Total assets (annual): USD 50.05MSEC XBRL filing
    • EPS (basic) (annual): USD-PER-SHARES 0SEC XBRL filing
    • Operating income (annual): USD 1.57MSEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES 0SEC XBRL filing
    • Gross profit (annual): USD 16.06MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-05-12FILINGQUARTERLY REPORT →
    2026-05-12FILINGFORM 8-K →
    2026-04-29FILINGFORM 8-K →
    2026-03-31FILINGANNUAL REPORT →
    2026-03-31FILINGFORM 8-K →
    2025-12-24 00:00 UTCINSIDER2 insider transactions — 2025-12
    2025-12-24INSIDERWHITMORE R JANET bought 1.5k sh — Director ~$3k
    2025-12-24INSIDERWHITMORE R JANET bought 1.0k sh — Director ~$2k
    2025-12-03FILINGFORM 8-K →
    2025-12-01FILINGFORM 8-K →
    2025-11-19 00:00 UTCINSIDER5 insider transactions — 2025-11
    2025-11-19INSIDERWHITMORE R JANET bought 5.0k sh — Director ~$10k
    2025-11-18INSIDERWHITMORE R JANET bought 267 sh — Director ~$0k
    2025-11-17INSIDERWHITMORE R JANET bought 5.0k sh — Director ~$9k
    2025-11-14INSIDERWHITMORE R JANET bought 19.8k sh — Director ~$34k
    2025-11-13FILINGFORM 8-K →
    2025-11-12FILINGQUARTERLY REPORT →
    2025-11-06FILINGCURRENT REPORT →
    2025-09-04FILINGCURRENT REPORT →
    2025-08-29FILINGCURRENT REPORT →
    2025-06-06 00:00 UTCINSIDER6 insider transactions — 2025-06 · net sell $148k 2 derivative
    2025-05-29 00:00 UTCINSIDER4 insider transactions — 2025-05 · $56.2M gross
    2024-12-31 00:00 UTCINSIDER5 insider transactions — 2024-12 5 derivative
    2024-10-29 00:00 UTCINSIDER14 insider transactions — 2024-10 4 derivative
    2024-09-24 00:00 UTCINSIDER14 insider transactions — 2024-09 · net buy $147k 1 derivative
    2024-08-27 00:00 UTCINSIDER8 insider transactions — 2024-08
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage